BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32168026)

  • 1. The antinociceptive effects of a dual kappa-delta opioid receptor agonist in the mouse formalin test.
    Ulker E; Toma W; White A; Uprety R; Majumdar S; Damaj MI
    Behav Pharmacol; 2020 Apr; 31(2&3):174-178. PubMed ID: 32168026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.
    Atigari DV; Uprety R; Pasternak GW; Majumdar S; Kivell BM
    Neuropharmacology; 2019 May; 150():217-228. PubMed ID: 30768946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.
    Atigari DV; Paton KF; Uprety R; Váradi A; Alder AF; Scouller B; Miller JH; Majumdar S; Kivell BM
    Neuropharmacology; 2021 Mar; 185():108445. PubMed ID: 33383089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior.
    Váradi A; Marrone GF; Eans SO; Ganno ML; Subrath JJ; Le Rouzic V; Hunkele A; Pasternak GW; McLaughlin JP; Majumdar S
    ACS Chem Neurosci; 2015 Nov; 6(11):1813-24. PubMed ID: 26325040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.
    Husbands SM; Neilan CL; Broadbear J; Grundt P; Breeden S; Aceto MD; Woods JH; Lewis JW; Traynor JR
    Eur J Pharmacol; 2005 Feb; 509(2-3):117-25. PubMed ID: 15733546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats.
    Kotlinska JH; Gibula-Bruzda E; Witkowska E; Chung NN; Schiller PW; Izdebski J
    Peptides; 2013 Jan; 39():103-10. PubMed ID: 23183627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
    Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
    Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.
    Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A
    J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes.
    Brissett DI; Whistler JL; van Rijn RM
    Eur J Pain; 2012 Mar; 16(3):327-37. PubMed ID: 22337177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
    Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
    J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation.
    Pasquinucci L; Turnaturi R; Montenegro L; Caraci F; Chiechio S; Parenti C
    Eur J Pharmacol; 2019 Mar; 847():97-102. PubMed ID: 30690004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.
    Neumeyer JL; Bidlack JM; Zong R; Bakthavachalam V; Gao P; Cohen DJ; Negus SS; Mello NK
    J Med Chem; 2000 Jan; 43(1):114-22. PubMed ID: 10633042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
    Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
    Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions.
    Saitoh A; Sugiyama A; Nemoto T; Fujii H; Wada K; Oka J; Nagase H; Yamada M
    Behav Brain Res; 2011 Oct; 223(2):271-9. PubMed ID: 21565223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones.
    Martin M; Matifas A; Maldonado R; Kieffer BL
    Eur J Neurosci; 2003 Feb; 17(4):701-8. PubMed ID: 12603260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.